Product Information
ALLOPURINOL 300 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0567 per EA under NDC 16571088509. Its NADAC has been published 86 times since Nov 6, 2024.
The High Outlier badge above means this manufacturer's average price in the allopurinol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571088509
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ALLOPURINOLApproval Type
Authorized Generic (NDA)
FDA Application
NDA016084On Market Since
9/21/2023
Pharmacological Classes
Price Statistics
The NADAC for ALLOPURINOL 300 MG TABLET has been published 86 times since Nov 6, 2024, and over the history we have for it it has declined 17.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0567 per EA |
|---|---|
| All-time high | $0.0690 (Apr 16, 2025) |
| All-time low | $0.0552 (Apr 22, 2026) |
| 52-week high | $0.0674 |
| 52-week low | $0.0552 |
| Median price | $0.0630 |
| Average price | $0.0630 |
| Largest weekly change | -17.0% (Nov 20, 2024) |
| Weeks tracked | 86 |
| Tracking since | Nov 6, 2024 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ALLOPURINOL 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALLOPURINOL 300 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0567 per EA (NDC 16571088509), effective Jun 24, 2026.
How has the price of ALLOPURINOL 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALLOPURINOL 300 MG TABLET has declined 17.2%. It has been tracked across 86 weekly CMS publications since Nov 6, 2024.
What are the highest and lowest recorded NADAC prices for ALLOPURINOL 300 MG TABLET?
Since Nov 6, 2024, the NADAC for ALLOPURINOL 300 MG TABLET has ranged from a low of $0.0552 (Apr 22, 2026) to a high of $0.0690 (Apr 16, 2025), with a median of $0.0630 per EA.
Are there cheaper alternatives to ALLOPURINOL 300 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as ALLOPURINOL 300 MG TABLET, but none are currently priced below it.
Who manufactures ALLOPURINOL 300 MG TABLET?
ALLOPURINOL 300 MG TABLET (NDC 16571088509) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification